| Suspended | Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia NCT06505993 | Marc Kiviniemi | N/A |
| Withdrawn | Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS NCT04452097 | Baylx Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome NCT07527130 | Mayo Clinic | — |
| Not Yet Recruiting | A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal an NCT07536308 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Not Yet Recruiting | Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), F NCT07149428 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Not Yet Recruiting | Noseguard for Prevention of Respiratory Infections in Real-World Use NCT07516977 | Daewoong Pharmaceutical Co. LTD. | N/A |
| Not Yet Recruiting | Dapagliflozin for Long COVID Syndrome NCT06907251 | Ottawa Heart Institute Research Corporation | Phase 3 |
| Recruiting | A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. NCT07445971 | ModeX Therapeutics, An OPKO Health Company | Phase 1 |
| Recruiting | Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID NCT07416539 | Rokote Laboratories Finland Oy | Phase 1 |
| Recruiting | Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults NCT07183709 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Active Not Recruiting | Study of VYD2311 for the Prevention of COVID-19 NCT07298434 | Invivyd, Inc. | Phase 3 |
| Not Yet Recruiting | Volatile Organic Compounds Analysis by GC-MS for Diagnostic of Hospitalised Patients With Respiratory Infectio NCT07352462 | Hospices Civils de Lyon | N/A |
| Not Yet Recruiting | Incidence of Bleeding, Thrombosis and Transfusion Requirements in ICU Patients With COVID-19 Supported With Ve NCT07352072 | Rigshospitalet, Denmark | — |
| Active Not Recruiting | Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 NCT07279766 | Tor Biering-Sørensen | Phase 4 |
| Active Not Recruiting | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age NCT07300839 | BioNTech SE | Phase 3 |
| Recruiting | A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes NCT07221162 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Not Yet Recruiting | Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Cov NCT07302295 | Hospices Civils de Lyon | N/A |
| Recruiting | Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study NCT07287137 | Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 4 |
| Not Yet Recruiting | Efficacy and Safety of NVX-CoV2705 NCT07086222 | Novavax | Phase 4 |
| Recruiting | Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated A NCT07215520 | CastleVax Inc. | Phase 2 |
| Not Yet Recruiting | Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Se NCT07217639 | Aptitude Medical Systems | N/A |
| Recruiting | Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19 NCT06871293 | Fundación Cardioinfantil Instituto de Cardiología | N/A |
| Active Not Recruiting | A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of NCT07222384 | BioNTech SE | Phase 3 |
| Active Not Recruiting | A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly NCT07261085 | Pfizer | — |
| Recruiting | A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to I NCT06810934 | Kara Chew | Phase 1 / Phase 2 |
| Active Not Recruiting | Safety and Immunogenicity of NVX-CoV2705 NCT07079670 | Sanofi | Phase 3 |
| Recruiting | Preparedness Through Respiratory Virus Epidemiology and Community Engagement NCT07147517 | University of California, San Diego | — |
| Active Not Recruiting | COVID-19 Reactogenicity NCT07051031 | Marcel Curlin | Phase 4 |
| Recruiting | Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregn NCT07051967 | Charite University, Berlin, Germany | — |
| Recruiting | Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COV NCT07157007 | Traws Pharma, Inc. | Phase 2 |
| Not Yet Recruiting | Correlation Between COVID-19 and Radiation Pneumonitis in Breast Cancer NCT07188116 | Zhejiang Hospital | — |
| Completed | Perioperative Outcomes for Children With Preoperative URTI Symptoms After COVID-19 Pandemic NCT07157111 | aijun xu | — |
| Not Yet Recruiting | "Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC NCT07156864 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 1 |
| Not Yet Recruiting | Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) NCT05633446 | Gylden Pharma Ltd | Phase 1 / Phase 2 |
| Recruiting | Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients NCT07197164 | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Phase 2 |
| Recruiting | Assessement of Effectiveness of Seawater Nasal Sprays on Sinonasal Symptoms NCT07262450 | Laboratoire de la Mer | N/A |
| Recruiting | COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise NCT07128095 | Indiana University | — |
| Recruiting | Neutralizing Power of Serum Antibodies - 2 NCT07085611 | Centre Hospitalier Régional d'Orléans | N/A |
| Active Not Recruiting | Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults NCT07095231 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations NCT07089706 | ModernaTX, Inc. | Phase 4 |
| Active Not Recruiting | A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participa NCT07069309 | BioNTech SE | Phase 3 |
| Recruiting | Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19 NCT06821113 | The University of Texas Health Science Center, Houston | N/A |
| Completed | Community-Led COVID-19 Testing Intervention to Address Mistrust NCT07166770 | Old Dominion University | N/A |
| Not Yet Recruiting | Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere NCT06928129 | Abbott Rapid Dx | N/A |
| Completed | A Study of S-892216 in Participants With COVID-19 NCT06928051 | Shionogi | Phase 2 |
| Withdrawn | The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19 NCT05371288 | University of California, Irvine | EARLY_Phase 1 |
| Active Not Recruiting | Impact of Covid-19 on Syphilis NCT07150871 | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria | — |
| Recruiting | SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGA NCT07030075 | Centre for Infectious Disease Research in Zambia | — |
| Completed | Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volu NCT06945276 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Not Yet Recruiting | Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection i NCT06780566 | The University of Hong Kong | N/A |
| Completed | Secondary Databased Post-marketing Surveillance Study of BNT162b2 NCT06743334 | Pfizer | — |
| Recruiting | The Role of Obesity in Severe COVID-19 Pathophysiology NCT06968442 | Franciscus Gasthuis | N/A |
| Active Not Recruiting | A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 an NCT06923137 | Pfizer | — |
| Completed | A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions. NCT07090486 | Pfizer | — |
| Completed | Long-Term Outcomes After ICU-Treated COVID-19 ARDS NCT07397156 | University in Zielona Góra | — |
| Withdrawn | Community-based Behavioral Intervention to Increase Vaccination Using MOST NCT06614361 | New York University | Phase 2 |
| Completed | EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN NCT06847204 | Zaeema Kanwal | Phase 1 / Phase 2 |
| Completed | Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single NCT06900114 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Withdrawn | Lot Consistency Study of COVID-19 and Influenza Combination Vaccine NCT06482359 | Novavax | Phase 2 / Phase 3 |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairm NCT06698549 | Aligos Therapeutics | Phase 1 |
| Not Yet Recruiting | Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza NCT06817096 | Azidus Brasil | Phase 3 |
| Recruiting | Dysbiosis & Long COVID NCT06825819 | University of Chicago | — |
| Completed | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impai NCT06568861 | Aligos Therapeutics | Phase 1 |
| Withdrawn | A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and Children NCT05630352 | BioNTech SE | Phase 1 |
| Recruiting | Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 NCT06099795 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Active Not Recruiting | A Rapid Diagnostic of Risk in Hospitalized Patients Using Machine Learning NCT05893420 | AgileMD, Inc. | N/A |
| Not Yet Recruiting | Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant NCT06768697 | Shanghai Public Health Clinical Center | EARLY_Phase 1 |
| Not Yet Recruiting | A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Boos NCT05911061 | WestVac Biopharma Co., Ltd. | Phase 3 |
| Not Yet Recruiting | A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccin NCT05911048 | WestVac Biopharma Co., Ltd. | Phase 2 |
| Completed | Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescript NCT06734741 | InBios International, Inc. | — |
| Active Not Recruiting | Project REMOTE (REimagining Measurements and Operations of Translational Endpoints) NCT06776367 | Biomedical Advanced Research and Development Authority | — |
| Completed | A Drug-drug Interaction Study of S-892216 Coadministered With Carbamazepime to Healthy Adult Participants NCT06751017 | Shionogi | Phase 1 |
| Recruiting | Noninvasive Neuromodulation in the Management of Post-COVID Musculoskeletal Pain NCT06723821 | University of Alcala | N/A |
| Recruiting | The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated With the NCT06608849 | Hellenic Institute for the Study of Sepsis | — |
| Active Not Recruiting | A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine NCT06291857 | Novavax | Phase 3 |
| Active Not Recruiting | A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine NCT06742281 | CyanVac LLC | Phase 2 |
| Recruiting | Characterization of the IFN-I Response in Subjects Who Experienced Severe or Mild Forms of COVID-19 NCT06703034 | Hospices Civils de Lyon | N/A |
| Terminated | Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine NCT06703190 | Pfizer | — |
| Recruiting | COVID-19 Booster and IIV Schedule in Immunocompromised Hosts NCT06599658 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Completed | Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19 NCT06694389 | ModernaTX, Inc. | Phase 3 |
| Completed | Covid Flu A/B and RSV 4 in 1 Diagnostic Test NCT07308158 | iHealth Labs inc | — |
| Completed | Evaluation of COVID-19 and Flu A/B 3 in 1 Combo Rapid Test NCT07190131 | iHealth Labs inc | — |
| Completed | A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults NCT06680375 | GlaxoSmithKline | Phase 1 |
| Completed | A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People NCT06683352 | BioNTech SE | Phase 1 / Phase 2 |
| Withdrawn | Phase 3 Lot Consistency Study of Trivalent Hemagglutinin Nanoparticle Influenza Vaccine NCT06485752 | Novavax | Phase 2 / Phase 3 |
| Completed | Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay NCT06689423 | Credo Diagnostics Biomedical Pte. Ltd. | — |
| Recruiting | Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopul NCT06631287 | Wes Ely | Phase 3 |
| Active Not Recruiting | Retail COVID-19 Study NCT06761612 | Biomedical Advanced Research and Development Authority | — |
| Recruiting | Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test NCT06744660 | Aptitude Medical Systems | N/A |
| Active Not Recruiting | A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectab NCT06672055 | Vaxart | Phase 2 |
| Completed | An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. NCT05911906 | University of Derby | Phase 4 |
| Completed | Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season NCT06603090 | Columbia University | N/A |
| Not Yet Recruiting | Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Bo NCT06587503 | University of Birmingham | Phase 4 |
| Recruiting | A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients NCT06672692 | DiaSorin Molecular LLC | N/A |
| Active Not Recruiting | A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers NCT06878170 | Rock BioMedical, Inc. | Phase 1 |
| Recruiting | Severe COVID-19 Infection in Children Presenting to EDs in Israel and England NCT06434701 | Hadassah Medical Organization | N/A |
| Withdrawn | Study of Cysteamine-pantetheine Disulfide (TTI-0102) in Mild to Moderate COVID-19 NCT05212662 | Thiogenesis Therapeutics, Inc. | Phase 2 |
| Not Yet Recruiting | Extended Remdesivir Infusion Combined With Nirmatrelvir/Ritonavir for Persistent SARS-CoV-2 Infection in Immun NCT06610643 | National Taiwan University Hospital | N/A |
| Active Not Recruiting | Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the NCT06633835 | Novavax | Phase 4 |
| Recruiting | Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection NCT06667063 | Zhongnan Hospital | — |
| Not Yet Recruiting | Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients NCT06452069 | Biodex S.A | N/A |
| Completed | COVID-19 Infection and Thoracic Anesthesia? NCT07118917 | Ankara University | — |
| Recruiting | Post-acute COVID-19 Sequelae in Denmark NCT06191302 | Hvidovre University Hospital | — |
| Completed | A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. NCT06586216 | Pfizer | Phase 1 |
| Completed | The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients NCT07244731 | Ankara University | — |
| Active Not Recruiting | A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants NCT06523153 | Invivyd, Inc. | Phase 1 |
| Active Not Recruiting | Singapore SARS-CoV-2 Human Challenge Study NCT06654973 | Tan Tock Seng Hospital | N/A |
| Active Not Recruiting | Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement NCT05841810 | University of California, San Diego | N/A |
| Recruiting | The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19 NCT06571136 | N5 Sensors | — |
| Completed | COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial NCT06547814 | University of North Carolina, Chapel Hill | N/A |
| Enrolling By Invitation | Drum Circle Synchrony Study 2c.a. NCT06513845 | Yale University | N/A |
| Enrolling By Invitation | Evaluating the Community Drum Circle NCT06513858 | Yale University | N/A |
| Recruiting | Music Mindfulness Study 2a. NCT06505226 | Yale University | N/A |
| Withdrawn | Trial to Evaluate Nitazoxanide for Treatment of Mild COVID-19 in Subjects Not at High Risk of Severe Illness NCT05157269 | Romark Laboratories L.C. | Phase 3 |
| Enrolling By Invitation | Evaluating Social Perception Dynamics NCT06513871 | Yale University | N/A |
| Withdrawn | Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe I NCT05157243 | Romark Laboratories L.C. | Phase 3 |
| Recruiting | Evaluating the Impact of Social Music NCT06513910 | Yale University | N/A |
| Completed | PA-001 Ph.1 Study in Healthy and Elderly Subjects NCT07518771 | PeptiDream Inc. | Phase 1 |
| Recruiting | Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement NCT05796505 | Yale University | N/A |
| Completed | To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA NCT06436911 | Entos Pharmaceuticals Inc. | Phase 1 / Phase 2 |
| Completed | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1 NCT06650462 | Old Dominion University | N/A |
| Recruiting | Dime La VerDAD: Verify, Debunk, and Disseminate NCT06417762 | University of Chicago | N/A |
| Completed | ACTIVATE in Public Housing NCT06075732 | Charles Drew University of Medicine and Science | N/A |
| Completed | Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults NCT06441968 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Withdrawn | Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents NCT05013983 | WestVac Biopharma Co., Ltd. | Phase 1 / Phase 2 |
| Completed | Applying Artificial Intelligence to Identify Subphenotypes of Acute Kidney Injury in Mexican Patients With Sev NCT06471101 | Instituto Nacional de Enfermedades Respiratorias | — |
| Withdrawn | GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects NCT06274853 | National Center for Advancing Translational Sciences (NCATS) | Phase 1 |
| Completed | Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study NCT07134738 | Avexima Diol LLC | — |
| Unknown | Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With NCT05996770 | Xiao Li，MD | — |
| Not Yet Recruiting | Collaborative Open Research Initiative Study (CORIS-1) NCT06357650 | Chisquares Incorporated | — |
| Recruiting | Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a B NCT06255626 | ANRS, Emerging Infectious Diseases | Phase 1 / Phase 2 |
| Terminated | Evaluating Emetine for Viral Outbreaks (EVOLVE) NCT05889793 | Johns Hopkins University | Phase 2 / Phase 3 |
| Completed | Impact of COVID-19 on Pregnancy Outcomes: a Systematic Review NCT06677281 | Zahedan University of Medical Sciences | — |
| Not Yet Recruiting | Effect of Virtual Reality in Patients With Long Covid-19 NCT06374446 | Istinye University | N/A |
| Completed | Mitigating Mental and Social Health Outcomes of COVID-19: a Counseling Approach NCT06142292 | Idaho State University | N/A |
| Completed | Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression NCT06119854 | City University of New York, School of Public Health | N/A |
| Terminated | Safety Study of SLV213 for the Treatment of COVID-19. NCT06146374 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients NCT06346210 | Uppsala University | — |
| Recruiting | Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis NCT06491966 | Sichuan Provincial People's Hospital | — |
| Unknown | SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19) NCT06288893 | JKT Biopharma Co., Ltd. | Phase 2 |
| Withdrawn | Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia) NCT05387317 | Murdoch Childrens Research Institute | Phase 3 |
| Recruiting | Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients. NCT06362499 | Universidade Federal do Rio Grande do Norte | N/A |
| Completed | Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines NCT06279871 | Arcturus Therapeutics, Inc. | Phase 3 |
| Completed | Relative Bioavailability Study of CX2101A for the Treatment of COVID-19 NCT06864182 | Heronova Pharmaceuticals | Phase 1 |
| Completed | Getting INFORMED and Living Well Among Asian Americans in California NCT05968300 | University of California, San Francisco | N/A |
| Completed | Risk in Devel Long-COVID in Contracting SARS-CoV-2 Infection After COVID-19 Vaccination in Relation to Vitamin NCT06452082 | IRCCS San Raffaele | — |
| Recruiting | Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment NCT06159283 | Jaehoon Ko | Phase 2 |
| Active Not Recruiting | Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases NCT05822219 | Northwestern University | N/A |
| Completed | A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain. NCT06291831 | Pfizer | — |
| Terminated | Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial NCT05946551 | Emory University | Phase 3 |
| Completed | Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years NCT06130410 | Pfizer | — |
| Completed | Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers NCT06831786 | Prince of Songkla University | EARLY_Phase 1 |
| Withdrawn | Impact of a History of Tonsillectomy or Adenoidectomy on the Severity of COVID-19 : AMYVID Study NCT05935566 | University Hospital, Angers | — |
| Recruiting | Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 NCT05886816 | University of Texas Southwestern Medical Center | Phase 2 |
| Recruiting | A Study of Healthy Microbiome, Healthy Mind NCT06020703 | Mayo Clinic | N/A |
| Completed | Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adop NCT06229444 | Evidation Health | N/A |
| Completed | Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19 NCT06251011 | Chulabhorn Hospital | N/A |
| Completed | Can Doctors Reduce COVID-19 Misinformation and Increase Vaccine Uptake in Ghana? A Cluster-randomised Controll NCT06191211 | London School of Economics and Political Science | N/A |
| Recruiting | Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19 NCT06348186 | University of the State of Santa Catarina | N/A |
| Completed | A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults NCT06237049 | Pfizer | Phase 2 |
| Completed | Effectiveness of a Nasal Spray on Viral Respiratory Infections NCT06278324 | CEN Biotech | N/A |
| Completed | Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Be NCT06207929 | Evidation Health | — |
| Completed | Study on the Safety and Efficacy of Meplazumab for Injection in Severe Patients With COVID-19 NCT05679479 | Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd | Phase 3 |
| Completed | PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED NCT06156215 | University of California, San Francisco | N/A |
| Withdrawn | A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza. NCT06163677 | Pfizer | — |
| Recruiting | A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae NCT06006884 | Mayo Clinic | — |
| Recruiting | Arginine Replacement Therapy in COVID-19 NCT05855330 | Emory University | Phase 2 |
| Completed | CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea NCT06052514 | Venkatesh Krishnamurthy | — |
| Recruiting | Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments NCT06082518 | Sunnybrook Health Sciences Centre | N/A |
| Active Not Recruiting | A Cross-sectional Study of Ocular Manifestations During the Covid-19 Pandemic in Hubei Province NCT06355128 | Zhongnan Hospital | — |
| Withdrawn | Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women NCT06997653 | Health Institutes of Turkey | Phase 2 |
| Completed | Prone Duration in COVID-19 ARDS NCT06765759 | Istanbul University - Cerrahpasa | — |
| Withdrawn | Tetrandrine Tablets Used in Hospitalized Adults With COVID-19 NCT05697029 | Peking University Third Hospital | Phase 4 |
| Recruiting | Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine NCT06402318 | The Geneva Foundation | — |
| Recruiting | Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India NCT06168019 | Boston University | — |
| Terminated | Study of Obeldesivir in Children and Adolescents With COVID-19 NCT05996744 | Gilead Sciences | Phase 2 / Phase 3 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate NCT06178991 | BioNTech SE | Phase 3 |
| Unknown | A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recom NCT06175494 | WestVac Biopharma Co., Ltd. | Phase 3 |
| Completed | Post Authorization Safety Profile of Booster IndoVac COVID-19 Vaccination NCT06690502 | PT Bio Farma | — |
| Unknown | Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID NCT06175468 | China Medical University Hospital | Phase 3 |
| Recruiting | Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 V NCT05858502 | Institut Pasteur | N/A |
| Completed | Promoting Engagement and COVID-19 Testing for Health NCT06141850 | Emory University | N/A |
| Completed | An Observational Study to Describe EVUSHELD™ (Tixagevimab/Cilgavimab) Pre-exposure Prophylaxis in Real-world S NCT06156982 | AstraZeneca | — |
| Completed | The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19 NCT06349655 | The First Affiliated Hospital of Zhengzhou University | — |
| Completed | Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use NCT06124638 | Abbott Rapid Dx | N/A |
| Withdrawn | Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE) NCT04413877 | University of Liege | — |
| Completed | Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID- NCT06141837 | Central Hospital, Nancy, France | — |
| Unknown | Evaluation of Safety, Tolerability, Reactogenicity, Immunogenicity of Baiya SARS-CoV-2 Vax 2 as a Booster for NCT05873374 | Baiya Phytopharm Co., Ltd. | Phase 2 |
| Completed | Self-management of Post COVID-19 Syndrome Using Wearable Biometric Technology NCT05507190 | University of Manitoba | N/A |
| Enrolling By Invitation | Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints NCT05831839 | Erasmus Medical Center | N/A |
| Completed | Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult NCT06099613 | EyeGene Inc. | Phase 1 / Phase 2 |
| Recruiting | A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Ch NCT05890612 | Pfizer | — |
| Completed | COVID-19 Vaccine Uptake Amongst Underserved Populations in East London NCT05866237 | Queen Mary University of London | N/A |
| Completed | A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 NCT06147063 | AstraZeneca | Phase 1 |
| Active Not Recruiting | Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Voluntee NCT05993325 | Cellid Co., Ltd. | Phase 3 |
| Active Not Recruiting | Leveraging Community Health Workers to Combat COVID-19 and Mental Health Misinformation in Haiti, Malawi, and NCT05997511 | Harvard Medical School (HMS and HSDM) | N/A |
| Completed | The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection NCT06065176 | Sarang K. Yoon, DO, MOH | Phase 4 |
| Completed | Additional Recombinant COVID-19 Humoral and Cell-Mediated Immunogenicity in Immunosuppressed Populations NCT06027229 | University of Wisconsin, Madison | Phase 2 |
| Unknown | Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol NCT06076421 | Harding Center for Risk Literacy | N/A |
| Recruiting | Effect of a Health Pathway for People With Persistent Symptoms Covid-19 NCT05787366 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Unknown | Understanding Adaptive Immune Response After COVID-19 Vaccination Boosters to Improve Vaccination Strategies i NCT06300853 | IRCCS Sacro Cuore Don Calabria di Negrar | N/A |
| Completed | Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel NCT06127108 | Abbott Rapid Dx | N/A |
| Completed | Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening NCT06124131 | Tulane University | N/A |
| Completed | A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in NCT06085924 | Pfizer | — |
| Completed | Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19 NCT06146361 | The University of Texas Health Science Center, Houston | N/A |
| Completed | The Impact of the COVID-19 Pandemic on the Patient in Need of an Intervention NCT05736822 | University Medical Center Groningen | — |
| Active Not Recruiting | Characteristics of the Anosmic Olfactory Mucosa NCT05562050 | Nicolai Nielsen | — |
| Terminated | Lupus Education Alliance Program NCT05243875 | Tulane University | N/A |
| Unknown | Commercially Available Cannabis Products for Immune Support NCT05944705 | Center For Interventional Pain and Spine | — |
| Completed | Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cor NCT06259656 | Vachira Phuket Hospital | N/A |
| Active Not Recruiting | Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data NCT05876377 | Pfizer | — |
| Completed | A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia NCT06016556 | Pfizer | — |
| Completed | Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines NCT05925127 | Novavax | Phase 2 / Phase 3 |
| Completed | Pharmacist Management of Paxlovid eVisits NCT06076863 | Kaiser Permanente | N/A |
| Completed | A Study to Determine the Tolerability of Intranasal LMN-301 NCT06030414 | Lumen Bioscience, Inc. | Phase 1 |
| Terminated | COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists NCT05926544 | University of North Carolina, Chapel Hill | N/A |
| Unknown | Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Par NCT06068569 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 3 |
| Withdrawn | Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults NCT06567457 | Clover Biopharmaceuticals AUS Pty | Phase 3 |
| Not Yet Recruiting | Palliative Care in Patients With COVID-19: Analysis of Costs of Hospitalization in Wards and Intensive Care Un NCT05897229 | University of Sao Paulo General Hospital | — |
| Withdrawn | Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL NCT05465876 | Sunnybrook Health Sciences Centre | Phase 2 |
| Unknown | Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition) NCT06068556 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 3 |
| Recruiting | TDCS Stimulation After Covid-19 Infection NCT06183424 | Istanbul Medipol University Hospital | N/A |
| Completed | A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects NCT06044233 | Zhejiang ACEA Pharmaceutical Co. Ltd. | Phase 1 |
| Completed | Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects NCT06063330 | Red Queen Therapeutics, Inc. | Phase 1 |
| Terminated | Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly NCT05977127 | Radboud University Medical Center | Phase 2 |
| Unknown | Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines NCT06091410 | Catholic Kwandong University | Phase 4 |
| Completed | Comparative Immunogenicity of Concomitant vs Sequential mRNA COVID-19 and Influenza Vaccinations NCT06020118 | Duke University | Phase 4 |
| Unknown | ECMO Braile Biomédica® in COVID-19 Patients NCT06086405 | Braile Biomedica Ind. Com. e Repr. Ltda. | — |
| Unknown | Baldachin: Ceiling HEPA-filtration to Prevent Nosocomial Transmission of COVID-19 NCT05648097 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis Wit NCT05803395 | Gruppo Italiano Malattie EMatologiche dell'Adulto | — |
| Withdrawn | Exercise Interventions in Post-acute Sequelae of Covid-19 NCT06065033 | University of Virginia | N/A |
| Active Not Recruiting | Cognitive Rehabilitation in Post-COVID-19 Condition NCT05494424 | Lovisenberg Diakonale Hospital | N/A |
| Completed | A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participa NCT06039449 | Invivyd, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in NCT05975060 | Novavax | Phase 2 / Phase 3 |
| Terminated | Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 Parosmia NCT06789952 | Washington University School of Medicine | N/A |
| Unknown | To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M NCT05733780 | Bioxytran Inc. | Phase 2 |
| Completed | Effect of Natural Food on Gut Microbiome and Phospholipid Spectrum of Immune Cells in COVID-19 Patients NCT05970861 | Asfendiyarov Kazakh National Medical University | N/A |
| Unknown | Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition. NCT06057025 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Phase 3 |
| Completed | Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in NCT06008470 | Kırıkkale University | — |
| Not Yet Recruiting | Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19 NCT04428801 | Celltex Therapeutics Corporation | Phase 2 |
| Recruiting | Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study NCT05868239 | KidSIM Simulation Program | N/A |
| Unknown | Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial NCT06043388 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Phase 1 |
| Unknown | Digital Health Literacy on COVID-19 for All: Co-creation and Evaluation of Interventions for Ethnic Minorities NCT06004323 | The Hong Kong Polytechnic University | N/A |
| Active Not Recruiting | A Real-World Study of JT001 for COVID-19 NCT06142201 | Shanghai Vinnerna Biosciences Co., Ltd. | — |
| Completed | Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences NCT05894655 | University of California, San Diego | N/A |
| Completed | RADx-UP CDCC Rapid Research Pilot Program "Culturally-relevant Community Connections (C3) to Increase COVID-19 NCT05918952 | Duke University | — |
| Withdrawn | Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults NCT05926440 | Clover Biopharmaceuticals AUS Pty | Phase 3 |
| Completed | Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines NCT05973006 | Novavax | Phase 3 |
| Unknown | Two-year Efficacy of Three Exercise Rehabilitation Strategies on Dyspnea in Patients Who Presented With Second NCT05890560 | Fondation Hôpital Saint-Joseph | — |
| Completed | A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals NCT05997290 | BioNTech SE | Phase 2 / Phase 3 |
| Unknown | Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated NCT05433272 | Sinovac Biotech (Colombia) S.A.S. | Phase 3 |
| Unknown | A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccine NCT05933512 | Sinocelltech Ltd. | Phase 2 |
| Completed | A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 20 NCT05972993 | GlaxoSmithKline | Phase 1 |
| Unknown | Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a NCT06006611 | Fifth Affiliated Hospital, Sun Yat-Sen University | — |
| Withdrawn | Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19) NCT05184101 | Australian National University | Phase 2 / Phase 3 |
| Completed | A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults NCT05960097 | GlaxoSmithKline | Phase 2 |
| Unknown | Exploring the Experiences, Expectations and Preferences of Patients With the UHS COVID-19 Follow-up Clinic NCT05799482 | University Hospital Southampton NHS Foundation Trust | — |
| Unknown | Exploring Gas Transfer and the Utility of Dynamic Chest Radiography in Long Covid Patients NCT05862896 | Liverpool University Hospitals NHS Foundation Trust | — |
| Completed | Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine NCT05933278 | PT Bio Farma | Phase 2 |
| Unknown | COVID-19 Infection NCT05926076 | Tianjin First Central Hospital | — |
| Completed | [14C] Study to Investigate the Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Parti NCT07080658 | Westlake Pharmaceuticals (Hangzhou) Co., Ltd. | Phase 1 |
| Recruiting | Immunosuppression and COVID-19 Boosters NCT05415267 | Kirby Institute | Phase 3 |
| Unknown | Analysis of Suicide Dynamics in Link to the COVID-19 Pandemic NCT06084143 | University Hospital, Strasbourg, France | — |
| Completed | The Effect of Smart Sensor Combined With APP for Individualized Precise Exercise Training in Long Covid-19 NCT05922865 | Shang-Lin Chiang | N/A |
| Unknown | Bioaerosol Sampling Device (BSD) Clinical Study NCT06047067 | Cantor BioConnect, Inc. | — |
| Completed | Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus NCT05867017 | The University of Texas Health Science Center at San Antonio | — |
| Unknown | A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults NCT06205524 | National Drug Clinical Trial Institute of the Second Affiliated Hospital of Bengbu Medical College | Phase 1 |
| Recruiting | Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities NCT06128928 | Johns Hopkins University | N/A |
| Withdrawn | Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster NCT05465902 | WestVac Biopharma Co., Ltd. | Phase 2 |
| Completed | Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strat NCT05822583 | University of Minnesota | Phase 4 |
| Completed | Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (Vid NCT05951920 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmaco NCT05840952 | Aligos Therapeutics | Phase 1 |
| Recruiting | A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection NCT06008860 | University of Chicago | Phase 4 |
| Completed | Study on Post-Acute COVID-19 Syndrome in Improvement of COVID-19 Rehabilitated Patients by Respiratory Trainin NCT06165835 | Tri-Service General Hospital | N/A |
| Completed | Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria NCT06162533 | Medical University of Graz | — |
| Withdrawn | COVID-19 Algorithm Treatment at Home NCT05413642 | Mario Negri Institute for Pharmacological Research | Phase 3 |
| Completed | Strength Training in Hospitalized Patients Using the Ghostly App: a Feasibility Study NCT05258500 | Vrije Universiteit Brussel | N/A |
| Unknown | Pandemic-Proofing Simulation-based Education NCT05931679 | Ottawa Hospital Research Institute | N/A |
| Unknown | Brain Function Changes Following COVID-19 Infection NCT05961618 | RenJi Hospital | — |
| Withdrawn | Lollipop COVID-19 Testing Study NCT05472077 | University of Wisconsin, Madison | N/A |
| Recruiting | COVID Infection in Pediatric Surgical Patient NCT05898529 | Salem Anaesthesia Pain Clinic | — |
| Active Not Recruiting | A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults NCT05736835 | CyanVac LLC | Phase 2 |
| Recruiting | A Nasal Treatment for COVID-19 NCT05799521 | Indiana University | Phase 2 |
| Unknown | Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease NCT05938140 | Chinese PLA General Hospital | Phase 4 |
| Unknown | Long COVID-19 and MAB Study NCT05508295 | MultiCare Health System Research Institute | — |
| Completed | Prevalence and Risk Factors of Anxiety and Depression Among Policemen During the Health Crisis Linked to COVID NCT06076876 | University Hospital, Strasbourg, France | — |
| Completed | Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learn NCT06052527 | Lizora LLC | — |
| Unknown | SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 NCT06050460 | Sinovac Life Sciences Co., Ltd. | Phase 1 |
| Completed | COVID-19 Self-testing IMPROVE NCT06576167 | Temple University | N/A |
| Completed | Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV) NCT05904054 | Immuno Cure 3 Limited | Phase 2 |
| Completed | INFLUENCE OF HIGH FREQUENCY CHEST WALL OSCILLATION IN HOSPITALIZED PATIENTS WITH COVID-19 NCT05705661 | Cairo University | N/A |
| Completed | A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-078 NCT05884554 | Pfizer | Phase 1 |
| Recruiting | COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics NCT05892549 | Direction Centrale du Service de Santé des Armées | — |
| Unknown | A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID NCT05904067 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Completed | Exploring the Effect of Video Interventions on Intentions for Continued COVID-19 Vaccination NCT05808413 | Sir Mortimer B. Davis - Jewish General Hospital | N/A |
| Active Not Recruiting | Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) NCT05881135 | Ohio State University | Phase 1 / Phase 2 |
| Unknown | Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine NCT05706324 | Wuhan BravoVax Co., Ltd. | Phase 1 |
| Withdrawn | LACTYFERRIN™ Forte and ZINC Defense™ and Standard of Care (SOC) vs SOC in the Treatment of Non-hospitalized Pa NCT05783180 | Jose David Suarez, MD | Phase 2 |
| Not Yet Recruiting | MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance NCT05722093 | Second Affiliated Hospital, School of Medicine, Zhejiang University | N/A |
| Unknown | Beta-glucans for Hospitalised Patients With COVID-19 NCT05465798 | Wohlstand Pharmaceutical | Phase 2 |